Research
Energy balance
HU6 treatment for 19 weeks significantly decreased body weight by -2.86 kg compared to placebo (P = .003).
HU6 may be an effective treatment option for weight loss in patients with obesity-related HFpEF.
StrongSupportsmedium confidence
HU6 (vs placebo) significantly decreased weight (between-group difference, -2.86 kg; P = .003).
Why this rating
Based on a randomized clinical trial design.
Source
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF
Ambarish Pandey et al. · JAMA Cardiology · 2025
rct · n=66Cited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →